Navigation Links
Developing Countries- Still The Least Likely To Use Contraception

A recent Analysis of the survey data from 55 developing countries has shown that, a ‘contraceptive gap’ separates the very poor from the rest of society.//

It was already well known that rates of use of modern contraceptives have risen over several decades, but it was not clear whether this was true for all socio-economic groups.

In this research published in the latest issue of PLoS Medicine, researchers based at World Health Organization HQ in Geneva brought together data from over 100 health and population surveys. They found that the contraceptive gap has remained over the years (and in some cases grown wider), even as the overall wealth of the countries (based on Gross Domestic Product) has risen.

However, a rise in GDP does not mean that family planning services automatically become more accessible to everyone. The authors say their findings show that governments and international health organizations need to focus their attention on providing contraceptive services in a way that will reach people who have very low incomes.

The researchers noted strong regional variations, with the lowest national rates of contraceptive use found in sub-Saharan Africa. Use among the poor was highest in South and Southeast Asia, and the largest inequalities in use were found in Latin America.

In a commentary published in the same issue of PLoS Medicine, Professor Duff Gillespie of the Bill and Melinda Gates Institute for Population and Reproductive Health says the new findings are important. He asks whether the lower use of modern contraceptives among is the poor due to a lack of desire for contraceptives, or because they do not have access to family planning services. He supports the view that the family planning needs of the poorest have yet to be adequately met.

Source-Eurekalert
SR
'"/>




Page: 1

Related medicine news :

1. Risk Of Developing Arthritis
2. Developing HIV fighter
3. Antibiotics Found To Increase The Risk Of Developing Breast Cancer
4. The Effectiveness Of Cancer Drug In Women At Risk Of Developing Cancer
5. Men Who at Risk Of Developing Prostate Cancer
6. Identifying The Risks Of Developing Schizophrenia
7. Patients With Severe Hemophilia At Risk Of Developing Osteoporosis
8. Cancer Patients At A Greater Risk Of Developing Blood Clots
9. Young Smokers at Increased Risk Of Developing a Heart Attack
10. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
(Date:8/27/2008)... The American Society for Therapeutic Radiology an...ist Audrey Evans, M.D., as its 2008 honorary membe...Ceremony held Tuesday, September 23, at 10:00 a.m....r. Evans has been on the forefront of the treatmen...as one of the co-founders of the original Ronald M...
(Date:8/27/2008)...inding could lead to new drugs in fight against ob... (HealthDay News) -- A chemical produced in the br... likelihood of becoming obese, according to a new ...a group of 33 people who had WAGR syndrome, a gene...illion people. WAGR is an acronym for the symptoms...
(Date:8/27/2008)...dding Velcade to standard drug therapy prolonged s... 27 (HealthDay News) -- Patients with multiple mye... lived longer and better by adding the drug Velcad...he finding could make multiple myeloma, a cancer o...a lethal disease. And it would be particularly val...
(Date:8/27/2008)...tudy also uncovers risks associated with treating ...DAY, Aug. 27 (HealthDay News) -- Scientists from t...st gene directly associated with the onset of seve... age-related macular degeneration that currently t...ericans. , The discovery, based on work with bo...
Breaking Medicine News(10 mins):Health News:ASTRO selects pediatric oncologist as 2008 honorary member 2Health News:Low Levels of Brain Chemical May Control Appetite 2Health News:Combination Therapy Helps to Combat Myeloma 2Health News:Combination Therapy Helps to Combat Myeloma 3Health News:Gene Linked to 'Dry' Macular Degeneration 2Health News:Gene Linked to 'Dry' Macular Degeneration 3
...be tackled by more action and less talk according ...ister// voiced support for higher taxes on drinks.... Scottish Health Action on Alcohol Problems (SHAAP...health problems and push for action to cut alcohol...
...he risk of colorectal cancer in laboratory mice wh...so be linked to colon cancer in humans, according ...t McGill University in a one-year study of 137 mic...et low in folic acid had a greater likelihood of d...
...ime Minister Manmohan Singh Thursday reviewed the ...ding chikungunya and dengue and called for setting... According to health ministry, over 160 people hav...ue across the country. In the case of chikungunya,...
...ase in the UK during the 1800s has made a comeback... number of cases have been rising from the late 19...causing great concern to government health agenci...amous poets like John Keats and Robert Louis Steve...
Other Medicine News:Health News:Alcohol Abuse Must be solved with Action 2Health News:Colon cancer Linked to low-folate diet 2Health News:Colon cancer Linked to low-folate diet 3Health News:TB Returns , Sharp Rise In Cases In UK 2
(Date:8/27/2008)... trial, expected by mid-2009 - - Data from second... ROCKVILLE, Md., Aug. 27 /...ay announced it has completed enrollment,and initi...hase 3,randomized clinical trials of LymphoStat-B(...pus erythematosus (SLE). Belimumab is being develo...
(Date:8/26/2008)...safely six weeks following surgical,treatment, RO...ix weeks following,bunion surgery, most patients, ...ack behind the wheel of a car again. A study publi...ne and Joint Surgery ( http://www.jbjs.org/ ),also...nts who underwent a,first metatarsal osteotomy (a ...
(Date:8/26/2008)...ros Corporation today announced the,publication of...ating,OMS103HP in arthroscopic anterior cruciate l...an investigational drug product that is added to,a... improve postoperative,knee function and motion, r...lier return to work. The article titled "Novel Dru...
(Date:8/25/2008)...re/ -- Anthera Pharmaceuticals,Inc., a privately h...ammatory drugs, today announced the initiation of ... with Near-term Cardiovascular,Inflammation Suppre...ct of,varespladib when administered to patients wi...event., The FRANCIS trial is designed to assess t...
Breaking Medicine Technology:Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer 24340 1Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer 24340 2CaringBridge 28R 29 Enhances Web Service by Adding Printable CaringBook Option 24336 1CaringBridge 28R 29 Enhances Web Service by Adding Printable CaringBook Option 24336 2CaringBridge 28R 29 Enhances Web Service by Adding Printable CaringBook Option 24336 3Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 1Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 2Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 3Human Genome Sciences Appoints David P Southwell to its Board of Directors 6709 4Clear Catheter Systems Completes 24600 Million Financing Opens Cleveland Office 24332 1Clear Catheter Systems Completes 24600 Million Financing Opens Cleveland Office 24332 2
...S ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis...obal biopharmaceutical,company, discussed results ...e for chemotherapy induced angiogenesis and,ration...Injectable,Suspension (paclitaxel protein-bound pa...) with VEGF inhibitor drugs like,bevacizumab (Avas...
...RANFORD, Conn., April 19, 2007 /PRNewswire-FirstCa...unced today that,preliminary interim clinical data...cetylase (HDAC) inhibitor being investigated,for t...ed at two,upcoming major medical meetings. , One o... clinical,results with belinostat will be made at ...
Other Medicine Technology:Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box.
Retrobulbar Needle, 25 g. Atkinson style bevel. Overall length 38 mm. 5/box.
Peribulbar Needle, 23 g. Atkinson style bevel. Overall length 31 mm. 5/box.
Scleral Blade tip 5700 style, straight. Dimensions: 15.2 mm (L) x 3.4 mm (W). Cut: 2.7 mm.
Medicine Products: